Matches in Nanopublications for { <http://bio2rdf.org/drugbank:DB05896> ?p ?o ?g. }
Showing items 1 to 12 of
12
with 100 items per page.
- drugbank:DB05896 type drugbank_vocabulary:Drug assertion.
- drugbank:DB05896 label "Sirna-027 [drugbank:DB05896]" assertion.
- drugbank:DB05896 seeAlso DB05896 assertion.
- drugbank:DB05896 description "Sirna-027 is a chemically modified short interfering RNA(siRNA) targeting Vascular Endothelial Growth Factor Receptor-1(VEGFR-1). VEGFR-1 is a key component of the clinically validated vascular endothelial growth factor (VEGF) pathway. Sirna-027 is developed by Sirna Therapeutics and is under the phase I of clinical trails. It is used to treat Macular degeneration." assertion.
- drugbank:DB05896 identifier "drugbank:DB05896" assertion.
- drugbank:DB05896 title "Sirna-027" assertion.
- drugbank:DB05896 drugbank_vocabulary:x-cas cas: assertion.
- drugbank:DB05896 drugbank_vocabulary:drugbank-id "DB05896" assertion.
- drugbank:DB05896 bio2rdf_vocabulary:x-identifiers.org DB05896 assertion.
- drugbank:DB05896 bio2rdf_vocabulary:uri "http://bio2rdf.org/drugbank:DB05896" assertion.
- drugbank:DB05896 bio2rdf_vocabulary:namespace "drugbank" assertion.
- drugbank:DB05896 bio2rdf_vocabulary:identifier "DB05896" assertion.